News Updates (18)

Aqilion and Merck Partner to Develop Groundbreaking Treatments for Chronic Inflammation

Swedish biotech firm Aqilion has partnered with global pharmaceutical company Merck to develop new treatments for chronic inflammation and immune dysfunction. The strategic collaboration will focus on discovering and commercializing inhibitors of the TAK1 protein, which is a crucial mediator in the inflammatory process. Merck’s upfront cash payment of EUR 10 million to Aqilion is…

Read More
News Updates (3)

East Capital Group strengthens Institutional Sales team with new hire, Adam Petersson Ellafi

East Capital Group, a global asset manager with 25 years of experience, has recently announced the addition of Adam Petersson Ellafi to its Investor Relations team as Relationship Manager for Institutional Sales in Sweden. This strategic move is part of East Capital Group’s effort to grow and strengthen its presence in its home market. Expanding…

Read More